Published • loading... • Updated
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit
Investors who bought Phreesia stock during the class period may seek compensation as the lawsuit alleges misleading statements about slowing demand and revenue visibility.
- On Thursday, The Rosen Law Firm reminded Phreesia, Inc. investors who purchased common stock between May 8, 2025, and March 30, 2026, of the July 13, 2026, lead plaintiff deadline.
- The lawsuit alleges defendants concealed material facts regarding Phreesia's slowing demand and reduced visibility in key revenue streams, notably weakened pharmaceutical marketing commitments within its Network Solutions segment.
- Investors purchasing stock during the Class Period may be entitled to compensation without out-of-pocket fees through a contingency fee arrangement; The Rosen Law Firm has recovered hundreds of millions for investors.
- Separately, The Rosen Law Firm announced a class action for Veritone, Inc. investors regarding securities purchased between October 14, 2025, and April 14, 2026, alleging inaccurate revenue classifications.
- To serve as lead plaintiff, individuals must move the Court by July 13, 2026, or remain absent class members without taking action at this time.
Insights by Ground AI
39 Articles
39 Articles
The Courier-Tribune+23 Reposted by 23 other sources
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit
Coverage Details
Total News Sources39
Leaning Left6Leaning Right4Center16Last UpdatedBias Distribution62% Center
Bias Distribution
- 62% of the sources are Center
62% Center
L 23%
C 62%
15%
Factuality
To view factuality data please Upgrade to Premium
